Benjamin H. Kaffenberger

4.7k total citations
174 papers, 1.6k citations indexed

About

Benjamin H. Kaffenberger is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Benjamin H. Kaffenberger has authored 174 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Dermatology, 57 papers in Epidemiology and 38 papers in Pathology and Forensic Medicine. Recurrent topics in Benjamin H. Kaffenberger's work include Autoimmune Bullous Skin Diseases (28 papers), Autoimmune and Inflammatory Disorders (26 papers) and Drug-Induced Adverse Reactions (26 papers). Benjamin H. Kaffenberger is often cited by papers focused on Autoimmune Bullous Skin Diseases (28 papers), Autoimmune and Inflammatory Disorders (26 papers) and Drug-Induced Adverse Reactions (26 papers). Benjamin H. Kaffenberger collaborates with scholars based in United States, Netherlands and Switzerland. Benjamin H. Kaffenberger's co-authors include John Trinidad, Shawn G. Kwatra, Misha Rosenbach, Matthew Zirwas, Nima Milani‐Nejad, Jessica Kaffenberger, Abraham M. Korman, Mark Bechtel, Scott A. Norton and Henry K. Wong and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin H. Kaffenberger

153 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin H. Kaffenberger United States 22 547 348 337 303 255 174 1.6k
Mar Llamas‐Velasco Spain 21 589 1.1× 276 0.8× 279 0.8× 267 0.9× 531 2.1× 167 1.6k
Wolfgang Salmhofer Austria 26 517 0.9× 205 0.6× 281 0.8× 276 0.9× 347 1.4× 54 1.5k
Nigel Burrows United Kingdom 23 411 0.8× 219 0.6× 290 0.9× 287 0.9× 98 0.4× 84 1.7k
Vito Di Lernia Italy 24 915 1.7× 363 1.0× 183 0.5× 295 1.0× 572 2.2× 113 1.7k
Camille Hua France 18 462 0.8× 114 0.3× 478 1.4× 179 0.6× 745 2.9× 43 1.7k
Aarnoud Huissoon United Kingdom 27 366 0.7× 249 0.7× 174 0.5× 380 1.3× 1.0k 4.0× 68 2.7k
Hong‐Shang Hong Taiwan 19 693 1.3× 327 0.9× 318 0.9× 513 1.7× 227 0.9× 67 2.4k
I. García‐Doval Spain 28 1.1k 2.0× 586 1.7× 335 1.0× 516 1.7× 1.2k 4.8× 165 2.8k
Elizabeth Lazaridou Greece 27 1.2k 2.2× 812 2.3× 823 2.4× 217 0.7× 517 2.0× 132 2.6k
E. Puzenat France 18 577 1.1× 200 0.6× 202 0.6× 270 0.9× 700 2.7× 68 1.3k

Countries citing papers authored by Benjamin H. Kaffenberger

Since Specialization
Citations

This map shows the geographic impact of Benjamin H. Kaffenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin H. Kaffenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin H. Kaffenberger more than expected).

Fields of papers citing papers by Benjamin H. Kaffenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin H. Kaffenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin H. Kaffenberger. The network helps show where Benjamin H. Kaffenberger may publish in the future.

Co-authorship network of co-authors of Benjamin H. Kaffenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin H. Kaffenberger. A scholar is included among the top collaborators of Benjamin H. Kaffenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin H. Kaffenberger. Benjamin H. Kaffenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plaza, Jose A., et al.. (2025). Eruptive keratoacanthoma secondary to immune checkpoint inhibitors: a narrative review. Archives of Dermatological Research. 317(1). 234–234.
2.
Krantz, Matthew S., Elizabeth J. P. Phillips, Aaron M. Drucker, et al.. (2025). HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US. JAMA Dermatology. 161(12). 1258–1258.
3.
Wall, Sarah, Sam Penza, Kevin K.W. Ho, et al.. (2025). Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd. Transplantation and Cellular Therapy. 31(2). S82–S83.
4.
Kaur, M., Ashley Gray, Michael J. Diaz, et al.. (2024). Dermatologic manifestations of acute graft-versus-host disease after solid organ transplantation: A systematic review. 1. 125–130. 1 indexed citations
5.
Gray, Ashley, Catherine Chung, Lucia Seminario‐Vidal, et al.. (2023). Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil. JAAD Case Reports. 36. 82–88. 2 indexed citations
6.
Korman, Abraham M., et al.. (2023). A description of Kaposi sarcoma risk factors and outcomes in HIV-positive and HIV-negative patients at a tertiary care medical center from 2005 to 2020. Archives of Dermatological Research. 315(7). 2159–2162. 6 indexed citations
7.
Anadkat, Milan J., Mario E. Lacouture, Adam Friedman, et al.. (2023). Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region. Frontiers in Oncology. 12. 975473–975473. 9 indexed citations
8.
Kaffenberger, Jessica, et al.. (2023). Characterizing risk factors for hospitalization for psoriasis patients. Archives of Dermatological Research. 315(6). 1541–1546.
9.
Diaz, Michael J., et al.. (2023). Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment. Journal of Personalized Medicine. 13(10). 1479–1479. 6 indexed citations
10.
Gray, Ashley, et al.. (2022). SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist. Current Dermatology Reports. 11(4). 252–262. 1 indexed citations
11.
Korman, Abraham M., et al.. (2022). Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis. Journal of the American Academy of Dermatology. 88(5). 1142–1145. 2 indexed citations
12.
Gru, Alejandro A., et al.. (2021). Fibrous Proliferations in Posttransplant Kaposi Sarcoma. PubMed Central. 14(6). 18–20.
13.
Wang, Henry E., et al.. (2021). Clinical and immunologic differences in cellulitis vs. pseudocellulitis. Expert Review of Clinical Immunology. 17(9). 1003–1013. 1 indexed citations
14.
Kaffenberger, Benjamin H., et al.. (2020). Optimizing Management of Otophyma: A Case Series Highlighting the Role of Surgical and Retinoid Therapy. Ear Nose & Throat Journal. 100(3_suppl). 253S–258S. 1 indexed citations
15.
Belzberg, Micah, Caolitao Qin, Kirsten M. Williams, et al.. (2020). 494 Association of granuloma annulare with type II diabetes, cigarette smoking, and liver disease: A case-control study. Journal of Investigative Dermatology. 140(7). S67–S67.
16.
Kaffenberger, Benjamin H., Michi M. Shinohara, Lucia Seminario‐Vidal, et al.. (2019). Characterisation and diagnosis of ulcers in inpatient dermatology consultation services: A multi‐centre study. International Wound Journal. 16(6). 1440–1444. 7 indexed citations
17.
Markova, Alina, et al.. (2019). Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014. Journal of the American Academy of Dermatology. 81(3). 740–748. 16 indexed citations
18.
Kaffenberger, Benjamin H., et al.. (2018). A Retrospective Review of New-onset Dermatitis in Patients Aged 60 Years or Older.. PubMed Central. 11(1). 19–20.
19.
Kaffenberger, Benjamin H., et al.. (2018). Cutaneous Manifestations of Infections in Solid Organ Transplant Recipients. Current Infectious Disease Reports. 20(7). 16–16. 1 indexed citations
20.
Duncan, J. R., David Carr, & Benjamin H. Kaffenberger. (2016). The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer. Journal of the American Academy of Dermatology. 75(1). 186–196. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mar Llamas‐Velasco Breakdown of academic impact, for papers by Wolfgang Salmhofer Breakdown of academic impact, for papers by Nigel Burrows Breakdown of academic impact, for papers by Vito Di Lernia Breakdown of academic impact, for papers by Camille Hua Breakdown of academic impact, for papers by Aarnoud Huissoon Breakdown of academic impact, for papers by Hong‐Shang Hong Breakdown of academic impact, for papers by I. García‐Doval Breakdown of academic impact, for papers by Elizabeth Lazaridou Breakdown of academic impact, for papers by E. Puzenat
Rankless by CCL
2026